A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation

ABSTRACT: The reason for this study is to see if the study drug LY3499446 is safe and effective in participants with solid tumors with KRAS G12C mutation.

DISEASE(S): Colorectal Cancer,Non-small Cell Lung Cancer,Advanced Solid Tumor,Colorectal Neoplasms,Carcinoma, Non-small-cell Lung

PROVIDER: 2322075 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR